# Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs

> **NCT04687410** · NA · UNKNOWN · sponsor: **Peter Vilmann MD, DSc, HC, FASGE** · enrollment: 68 (estimated)

## Conditions studied

- Pancreas Neoplasm
- Pancreas Cancer

## Interventions

- **DEVICE:** ProControl, MediGlobe
- **DEVICE:** TopGain, Medi-Globe

## Key facts

- **NCT ID:** NCT04687410
- **Lead sponsor:** Peter Vilmann MD, DSc, HC, FASGE
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-15
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2020-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04687410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04687410, "Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04687410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*